Stocktoria
RAPID MICRO BIOSYSTEMS, INC. RPID
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2021-07-15
RAPID MICRO BIOSYSTEMS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -141.1% | -178.0% | -251.2% | -369.0% | -203.3% |
| Net margin | -140.3% | -167.2% | -233.0% | -354.9% | -316.5% |
| FCF margin | -95.0% | -162.3% | -208.4% | -381.1% | -250.4% |
| Return on assets | -63.0% | -47.8% | -36.6% | -31.9% | -30.5% |
| Return on equity | -141.9% | -62.2% | -44.5% | -37.0% | -33.3% |
| Debt / equity | 0.57× | 0.00× | — | 0.00× | 0.00× |
| Current ratio | 3.31 | 4.61 | 6.34 | 7.27 | 12.01 |
| Revenue growth | 19.7% | 24.6% | 31.4% | -26.3% | 44.5% |
Source: SEC EDGAR filings · CIK 0001380106 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.